^
Association details:
| Biomarker: | AEBP1 expression |
|---|---|
| Cancer: | Colon Cancer |
| Regimen: | FOLFIRI (irinotecan + leucovorin calcium + 5-fluorouracil) |
| Direction: | Sensitive |
Evidence:
Source:
Title:
Screening prognostic genes related to leucovorin, fluorouracil, and irinotecan treatment sensitivity by performing co-expression network analysis for colon cancer
Published date:
11/29/2022
Excerpt:
Gene expression profiles of 21 patients with advanced colorectal cancer who received chemotherapy based on FOLFIRI were obtained...Therefore, AEBP1, BGN, and TAGLN have been identified as potential biomarkers related to the response to FOLFIRI treatment of colon cancer….We found that AEBP1, BGN, and TAGLN, as potential predictive biomarkers, may play an important role in the response to FOLFIRI treatment of colon cancer and as a precise molecular target associated with chemotherapy response in colon cancer.
DOI:
10.3389/fgene.2022.928356
